Litcius/Paper detail

Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

Carlota Dobaño, Rebeca Santano, Alfons Jiménez, Marta Vidal, Jordi Chi, Natalia Rodrigo Melero, Matija Popovic, Rubén López-Aladid, Laia Fernández‐Barat, Marta Tortajada, Francisco Carmona-Torre, Gabriel Reina, Antoni Torres, Alfredo Mayor, Carlo Carolis, Alberto L. García‐Basteiro, Ruth Aguilar, Gemma Moncunill, Luís Izquierdo

2021Translational research112 citationsDOIOpen Access PDF

Topics & Concepts

ImmunogenicityAntibodyVirologySeroprevalenceImmunityImmunologyBiologyEpitopeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusImmunoglobulin GImmune systemMedicineCoronavirus disease 2019 (COVID-19)SerologyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies | Litcius